Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

Personalized Medicine — Trends in Molecular Diagnosticsy

(2012) Julie Hoggatt   Molecular Diagnosis & Therapy

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

(2011) L. H. Butterfield et al.   CLINICAL CANCER RESEARCH

Association of Circulating Levels of Leptin and Adiponectin With Metabolic Syndrome and Coronary Heart Disease in Patients With Various Coronary Risk Factors

(2011) Yutaka Kajikawa et al.   International Heart Journal

Modeling treatment-resistant depression

(2011) Benjamin Adam Samuels et al.   NEUROPHARMACOLOGY

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia

(2011) Paul C. Guest et al.   PSYCHONEUROENDOCRINOLOGY

Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective

(2010) Erik H. F. Wong et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients

(2010) P C Guest et al.   MOLECULAR PSYCHIATRY

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

(2009) Tomohiko Sato et al.   NEUROBIOLOGY OF AGING

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

Body Weight and Plasma Levels of Ghrelin and Leptin during Treatment with Olanzapine

(2008) Bong-Jo Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE